The Nation - News from Oct. 15, 1986
- Share via
Harvard Medical School professors said about 50,000 patients are suffering renewed blindness and facial spasms because an experimental drug was shelved when its maker could not find liability insurance. The patients suffer from a rare neurological disorder, blepharospasm, which causes involuntary muscle spasms and can force eyes shut. The drug, Oculinum, is awaiting approval by the Food and Drug Administration.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
